FLOT1 and breast cancer: Recent findings have linked flotillin overexpression with various types of cancers, and our data show that flotillin-1 depletion in breast cancer cells may result in overexpression of the EGFR.53 Therefore, flotillins evidently regulate the proliferative signalling axis by several means, including receptor activation, degradation and downstream signalling.